Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Indexado en
  • Índice Copérnico
  • Google Académico
  • Abrir puerta J
  • Revista GenámicaBuscar
  • Infraestructura Nacional del Conocimiento de China (CNKI)
  • Biblioteca de revistas electrónicas
  • Búsqueda de referencia
  • Universidad Hamdard
  • EBSCO AZ
  • OCLC-WorldCat
  • Biblioteca Virtual de Biología (vifabio)
  • publones
  • Fundación de Ginebra para la educación y la investigación médicas
  • Pub Europeo
  • ICMJE
Comparte esta página

Abstracto

Perspectives of HCC-Treating Clinicians: Identifying Facilitators and Barriers to Palliative Care Referral for Individuals with Hepatocellular Carcinoma

James Baker

The referral of individuals with hepatocellular carcinoma (HCC) to palliative care remains a complex and underexplored area. This study aims to identify the factors that either promote or hinder palliative care referral as reported by clinicians treating patients with HCC. Through the development of a comprehensive code book, all interviews were coded using axial coding, with selective coding employed to pinpoint facilitators and barriers of palliative care referral. The identified facilitators included the invaluable support during transitions, assistance in managing specific symptoms, provision of psychosocial support, and positive past experiences with palliative care referrals. On the other hand, barriers encompassed concerns about feasibility, limited knowledge about palliative care and suitable candidates, absence of symptoms necessitating external referral, and fears that palliative care might be perceived as a sign of hopelessness. Participants recognized the benefits of palliative care at certain stages of the disease trajectory while also identifying barriers related to feasibility, perceived lack of need, limited awareness, and concerns about hopelessness. These findings provide actionable insights for future research to enhance the advantages of palliative care and address obstacles for individuals with HCC effectively.